These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 15906754

  • 21. The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
    Sheu BS, Huang JJ, Yang HB, Huang AH, Wu JJ.
    Aliment Pharmacol Ther; 2003 May 15; 17(10):1283-90. PubMed ID: 12755841
    [Abstract] [Full Text] [Related]

  • 22. Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
    Lamouliatte H, Cayla R, Zerbib F, Forestier S, de Mascarel A, Joubert-Collin M, Mégraud F.
    Am J Gastroenterol; 1998 Sep 15; 93(9):1531-4. PubMed ID: 9732938
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of lansoprazole in eradication of Helicobacter pylori.
    Takimoto T, Ido K, Taniguchi Y, Satoh K, Saifuku K, Kihira K, Yoshida Y, Kimura K.
    J Clin Gastroenterol; 1995 Sep 15; 20 Suppl 2():S121-4. PubMed ID: 7594327
    [Abstract] [Full Text] [Related]

  • 24. Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer.
    Silva FM, Zaterka S, Eisig JN, Chehter EZ, Chinzon D, Laudanna AA.
    Rev Hosp Clin Fac Med Sao Paulo; 2001 Sep 15; 56(1):11-6. PubMed ID: 11378678
    [Abstract] [Full Text] [Related]

  • 25. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T, Shirai N, Takashima M, Xiao F, Hanai H, Sugimura H, Ohashi K, Ishizaki T, Kaneko E.
    Clin Pharmacol Ther; 2001 Mar 15; 69(3):158-68. PubMed ID: 11240980
    [Abstract] [Full Text] [Related]

  • 26. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    Giannini E, Romagnoli P, Fasoli A, Chiarbonello B, Malfatti F, Botta F, Risso D, Lantieri PB, Savarino V, Testa R.
    Am J Gastroenterol; 2000 Oct 15; 95(10):2762-7. PubMed ID: 11051345
    [Abstract] [Full Text] [Related]

  • 27. How can the current strategies for Helicobacter pylori eradication therapy be improved?
    Ford A, Moayyedi P.
    Can J Gastroenterol; 2003 Jun 15; 17 Suppl B():36B-40B. PubMed ID: 12845349
    [Abstract] [Full Text] [Related]

  • 28. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S, Japan Helicobacter pylori Eradication Study Group.
    J Gastroenterol; 2003 Jun 15; 38(4):339-47. PubMed ID: 12743773
    [Abstract] [Full Text] [Related]

  • 29. Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
    Maconi G, Russo A, Imbesi V, Cucino C, Bianchi Porro G.
    Dig Liver Dis; 2000 May 15; 32(4):275-80. PubMed ID: 11515622
    [Abstract] [Full Text] [Related]

  • 30. Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Vallve M, Vergara M, Gisbert JP, Calvet X.
    Aliment Pharmacol Ther; 2002 Jun 15; 16(6):1149-56. PubMed ID: 12030958
    [Abstract] [Full Text] [Related]

  • 31. Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India.
    Bhasin DK, Sharma BC, Ray P, Pathak CM, Singh K.
    Helicobacter; 2000 Jun 15; 5(2):84-7. PubMed ID: 10849056
    [Abstract] [Full Text] [Related]

  • 32. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y, Ford AC, Khan KJ, Gisbert JP, Forman D, Leontiadis GI, Tse F, Calvet X, Fallone C, Fischbach L, Oderda G, Bazzoli F, Moayyedi P.
    Cochrane Database Syst Rev; 2013 Dec 11; (12):CD008337. PubMed ID: 24338763
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
    Lamouliatte H, Perie F, Joubert-Collin M.
    Gastroenterol Clin Biol; 2000 May 11; 24(5):495-500. PubMed ID: 10891736
    [Abstract] [Full Text] [Related]

  • 34. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
    Auesomwang C, Maneerattanaporn M, Chey WD, Kiratisin P, Leelakusolwong S, Tanwandee T.
    J Gastroenterol Hepatol; 2018 Nov 11; 33(11):1822-1828. PubMed ID: 29804294
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection.
    Bago J, Galović A, Belosić Halle Z, Bilić A, Bevanda M, Bago P.
    Wien Klin Wochenschr; 2004 Jul 31; 116(14):495-9. PubMed ID: 15379146
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan.
    Kawai T, Kawakami K, Mikinori K, Takei K, Itoi T, Moriyasu F, Takagi Y, Aoki T, Watanebe K, Matsumoto Y, Rimbara E, Noguchi N, Sasatsu M.
    Hepatogastroenterology; 2007 Mar 31; 54(74):649-54. PubMed ID: 17523342
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
    Miwa H, Nagahara A, Sato K, Ohkura R, Murai T, Shimizu H, Watanabe S, Sato N.
    J Gastroenterol Hepatol; 1999 Apr 31; 14(4):317-21. PubMed ID: 10207779
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.